Literature DB >> 15157337

[Determination and comparison of anti-SARS antibody in children and adults].

Jing-Han Liu1, Shu-Xuan Ma, Xi-Lin Ouyang, Hai-Bao Wang, Yang Yu, Xi-Jin Li, Ting Zhang, Suo-Qin Tang.   

Abstract

To investigate the positive rate of anti-SARS antibody in children and adults without SARS, 197 paediatric patients under 14 years old from inpatient and outpatient department of our hospital, 156 healthy children pupils from primary school, 453 adult patients over 18 years old from inpatient and outpatient department of our hospital and other 502 healthy adult blood donors were selected. Anti-SARS antibodies were determined by anti-SARS specific antibody detection kit and ELISA method. The results showed that both the positive rates of IgG antibody in paediatric patients and healthy children were about 2% (4/197 and 3/156), while the positive rates in adult patients and healthy adults were about 0.2% (1/453 and 1/502). The difference between the positive rates of children and adults was significant (chi(2) = 11.61, P < 0.001). IgM antibody was negative in all the samples. It is concluded that the anti-SARS IgG antibody positive rate in children was obvious higher than that in adults. This may be the cause why the cases with SARS in children is much less than in adults.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157337

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

1.  Children's vaccines do not induce cross reactivity against SARS-CoV.

Authors:  Yang Yu; Huali Jin; Ze Chen; Qingling L Yu; Yijie J Ma; Xiaolin L Sun; Bin Wang
Journal:  J Clin Pathol       Date:  2007-02       Impact factor: 3.411

2.  Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?

Authors:  Jinglu Lyu; Tianyu Miao; Jiajia Dong; Ranran Cao; Yan Li; Qianming Chen
Journal:  Med Hypotheses       Date:  2020-05-15       Impact factor: 1.538

3.  SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge.

Authors:  Madeshwari Ezhilan; Indhu Suresh; Noel Nesakumar
Journal:  Measurement (Lond)       Date:  2020-08-08       Impact factor: 5.131

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.